A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
Recruiting · NCT07759128 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder | anxiety disorder, generalized anxiety disorder, psychiatric disorder | Recruiting | Phase 3 | 2026-09-22 | NCT07759128 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 26 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinical Neuroscience Solutions, LLC | Jacksonville | United States | 5 |
| Del Sol Research Management | Tucson | United States | 5 |
| FutureSearch Trials of Dallas | Dallas | United States | 13 |
| Manhattan Behavioral Medicine PLLC | New York | United States | 2 |
| Sarkis Clinical Trials - Gainesville | Gainesville | United States | 3 |
| Vector Clinical Trials - Las Vegas | Las Vegas | United States | 2 |